fashion -WSS

fashion

author：entertainment 2025-09-10 08:20:47 - browse：45

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Listen: Who gets the credit for GLP

focus

WSS

The Sacklers, horror, and ‘The Fall of the House of Usher’

Medicaid, Medicare dual

FDA approves potent Eli Lilly obesity drug, Zepbound

Researchers use wearables data and AI to predict preterm birth risk

Diversify hospital leadership teams to protect BIPOC patient health

Just how powerful is the placebo effect?

entertainment

fashion

leisure time

Cancer drug shortages should be causing more outrage

Why do women spend more than men on medical expenses?

Bright Health sells Medicare Advantage business to Molina

Just how powerful is the placebo effect?

Heart attack and stroke risk calculators need revising

Researchers use wearables data and AI to predict preterm birth risk

Affirmative action in medical school literally saved lives

Medicare will require more price transparency from hospitals

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare drug price negotiation program allowed for now

knowledge

FDA approves Recor Medical high blood pressure device

Ionis has late

Biogen shutters digital health group, ends Apple study, in cost cutting move

The Sacklers, horror, and ‘The Fall of the House of Usher’

Just how powerful is the placebo effect?

FDA approves Recor Medical high blood pressure device

entertainment

explore

focus

knowledge